Back
VirnetX Holding 10K Form
Sell
14
VHC
VirnetX Holding
Last Price:
4.54
Seasonality Move:
34.55%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-15 | 10Q | VHC/VirnetX Holding Quarterly |
2023-11-09 | 10Q | VHC/VirnetX Holding Quarterly |
2023-08-11 | 10Q | VHC/VirnetX Holding Quarterly |
2023-05-15 | 10Q | VHC/VirnetX Holding Quarterly |
2022-11-08 | 10Q | VHC/VirnetX Holding Quarterly |
2022-08-09 | 10Q | VHC/VirnetX Holding Quarterly |
Receive VHC News And Ratings
See the #1 stock for the next 7 days that we like better than VHC
VHC Financial Statistics
Sales & Book Value
Annual Sales: | $7K |
---|---|
Cash Flow: | $-3.22M |
Price / Cash Flow: | 0 |
Annual Sales: | $12.20 |
Price / Book: | 0.37 |
Profitability
EPS (TTM): | -5.33000 |
---|---|
Net Income (TTM): | $-19.07M |
Gross Margin: | $212.54M |
Return on Equity: | -36% |
Return on Assets: | -31.66% |
VirnetX Holding Earnings Forecast
Key VirnetX Holding Financial Ratios
- The Gross Profit Margin over the past 23 years for VHC is 70.23%.
- The Selling, General & Administrative Expenses for VHC have been equal to 310,557.14% of Gross Profit Margin.
- The Research & Development expenses have been 138,757.14% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of VHC is -398,157.14% of Total Revenues.
- Per Share Earnings over the last 26 years have been positive in 14 years.
VirnetX Holding Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Software |
Sector: | Information Technology |
Current Symbol: | VHC |
CUSIP: | 92823T |
Website: | virnetx.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 6.17 |
Quick Ratio: | 6.13 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
VHC Technical Analysis vs Fundamental Analysis
Sell
14
VirnetX Holding (VHC)
is a Sell
Is VirnetX Holding a Buy or a Sell?
-
VirnetX Holding stock is rated a Sell
The current VirnetX Holding [VHC] share price is $4.54. The Score for VHC is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.